Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Tocris Bioscience™ RECTAS

IKBKAP pre-mRNA splicing modulator
$212.50 - $891.50
Specifications
Chemical Name or Material | 2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine |
---|---|
CAS | 101862-47-9 |
Target | DNA, RNA and Protein Synthesis Compounds |
Molecular Formula | C10H8ClN5O |
Purity | 0.98 |
Description
RECTAS (rectifier of aberrant splicing) is a pre-mRNA splicing modulator of the IKBKAP (inhibitor of κ light polypeptide gene enhancer in B-cells, kinase complex associated protein) gene. It corrects aberrant IKBKAP splicing in vitro in cellular models of familial dysautonomia and in vivo in transgenic mice. In combination with Phenylbutyric acid (Cat. No. 2682), RECTAS rescues PARK7 aberrant splicing and neuronal cell loss in a midbrain organoid model of familial Parkinson's disease. Orally bioavailable and brain penetrant.Specifications
2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine | |
DNA, RNA and Protein Synthesis Compounds | |
0.98 |
101862-47-9 | |
C10H8ClN5O |
Safety and Handling
Recommended Storage : Store at -20°C
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title